0001181431-12-002294.txt : 20120111 0001181431-12-002294.hdr.sgml : 20120111 20120111180802 ACCESSION NUMBER: 0001181431-12-002294 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111220 FILED AS OF DATE: 20120111 DATE AS OF CHANGE: 20120111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Malley Thomas CENTRAL INDEX KEY: 0001403322 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-23155 FILM NUMBER: 12522897 MAIL ADDRESS: STREET 1: 295 CLAYTON CITY: DENVER STATE: CO ZIP: 80206 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNAGEVA BIOPHARMA CORP CENTRAL INDEX KEY: 0000911326 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 561808663 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SPRING STREET STREET 2: SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: (781) 357-9900 MAIL ADDRESS: STREET 1: 128 SPRING STREET STREET 2: SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: TRIMERIS INC DATE OF NAME CHANGE: 19970516 4/A 1 rrd329541.xml MALLEY DEC 2011 OPTION GRANT AMENDMENT X0304 4/A 2011-12-20 2011-12-21 0 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001403322 Malley Thomas SYNAGEVA BIOPHARMA CORP. 128 SPRING ST STE 520 LEXINGTON MA 02421 1 0 0 0 Stock Option (Right to Buy) 23.00 2011-12-20 4 A 0 15000 0.00 A 2021-12-19 Common Stock 15000 15000 D This amendment is filed solely to correct a clerical error in the initial filing. In this regard the number of options acquired was incorrectly included in the disposition column rather than the acquisition column. 1/36 of the shares subject to this option vest and become exercisable on December 2, 2011 and monthly thereafter. /s/ Marc A. Rubenstein, Attorney-in-Fact 2012-01-11